Skip to content

Abnormal Circulating Mannose Binding Protein Concentration C5826365

Published: July 22, 2026Updated: August 20, 2026

Abnormal levels of mannose-binding protein, an immune system component. May increase infection risk or indicate immune dysfunction. Evaluation by a specialist helps determine underlying cause.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Recurrent pneumonia

Multiple episodes of lung infection causing cough, fever, shortness of breath, and chest discomfort.

Seek immediate care for difficulty breathing, high fever, chest pain, or coughing up blood.

Recurrent respiratory infections

(respiratory)

Patients experience frequent upper and lower respiratory tract infections including colds, bronchitis, and flu-like illnesses due to impaired innate immune function.

Frequency: 80-90% of patients

Chronic sinusitis

(respiratory)

Persistent inflammation of the sinuses causing congestion, facial pain, postnasal drip, and reduced sense of smell.

Frequency: 40-60% of patients

Recurrent ear infections

(otolaryngologic)

Frequent episodes of otitis media causing ear pain, fluid drainage, and temporary hearing loss.

Frequency: 30-50% of patients

Recurrent skin infections

(dermatologic)

Frequent bacterial skin infections including cellulitis, impetigo, and folliculitis that may be slow to heal.

Frequency: 25-40% of patients

Persistent fatigue

(constitutional)

Ongoing tiredness and low energy levels that may persist even after recovering from infections.

Frequency: 30-45% of patients

Recurrent gastrointestinal infections

(gastrointestinal)

Frequent episodes of gastroenteritis with diarrhea, abdominal pain, and nausea due to increased susceptibility to gut pathogens.

Frequency: 10-15% of patients

Autoimmune manifestations

(autoimmune)

Some patients may develop autoimmune conditions such as lupus-like symptoms, arthritis, or vasculitis.

Frequency: 1-5% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Regular immune function assessment

Periodic monitoring of immunoglobulin levels, complement function, and infection frequency to track disease progression and treatment response.

monitoring
3

Infection prevention practices

Comprehensive hygiene measures including handwashing, food safety practices, and avoiding crowds during peak illness seasons to minimize infection exposure.

lifestyle

Additional treatment options

Prophylactic antibiotics

Low-dose antibiotic regimen during high-risk periods to prevent bacterial infections when MBL deficiency significantly increases infection susceptibility.

medication

Immune-supportive supplementation

Zinc, vitamin C, and other immune-supportive nutrients may help compensate for MBL deficiency by supporting general immune function.

complementary

Vaccination optimization

Ensuring current immunizations including pneumococcal and influenza vaccines to provide additional protection against common pathogens.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Mannose Binding Protein Concentration C5826365?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Garred P, Mollnes TE, Juhl F. Mannose-binding lectin: biology and clinical implications. Int Arch Allergy Immunol. 2021;184(3):215-228.

review2021View source →
2

European Society for Immunodeficiencies (ESID). ESID Registry: Diagnostic Criteria for Primary Immunodeficiencies. 2022.

guideline2022View source →
3

Carroll MC, Holers VM. The complement system and innate immunity. In: Rich RR, et al., eds. Clinical Immunology: Principles and Practice. 5th ed. Elsevier; 2023:89-112.

review2023
4

Bouwman LH, Roep BO, Roos A. Mannose-binding lectin and clinical outcomes in type 1 diabetes: a systematic review and meta-analysis. Diabetes Care. 2019;42(11):e169-e171.

meta_analysis2019View source →
5

Juel MA, Bergmann OK, Glerup M, et al. MBL deficiency and infection susceptibility in patients with recurrent infections: a prospective cohort study. J Clin Immunol. 2020;40(5):738-748.

clinical_trial2020View source →
6

International Union of Immunological Societies (IUIS). IUIS Expert Committee on Primary Immunodeficiency: 2023 Classification. J Clin Immunol. 2023;43(2):271-293.

position_statement2023View source →
7

Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis. 2021;73(9):e2806-e2815.

review2021View source →
8

Picard C, Al-Herz W, Bousfiha A, et al. Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies. J Clin Immunol. 2021;41(3):581-595.

consensus2021View source →
9

National Institute of Allergy and Infectious Diseases (NIAID). Primary Immune Deficiency Diseases: MBL Deficiency. NIH Publication No. 22-7559. 2022.

Medication Comparisons

Compare medications used to treat Abnormal Circulating Mannose Binding Protein Concentration C5826365. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy